rs41297317

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001011658.4(TRAPPC2):​c.*2035C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000998 in 112,224 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 28 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., 28 hem., cov: 23)
Failed GnomAD Quality Control

Consequence

TRAPPC2
NM_001011658.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.245

Publications

0 publications found
Variant links:
Genes affected
TRAPPC2 (HGNC:23068): (trafficking protein particle complex subunit 2) The protein encoded by this gene is thought to be part of a large multi-subunit complex involved in the targeting and fusion of endoplasmic reticulum-to-Golgi transport vesicles with their acceptor compartment. In addition, the encoded protein can bind c-myc promoter-binding protein 1 and block its transcriptional repression capability. Mutations in this gene are a cause of spondyloepiphyseal dysplasia tarda (SEDT). A processed pseudogene of this gene is located on chromosome 19, and other pseudogenes are found on chromosomes 8 and Y. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2010]
TRAPPC2 Gene-Disease associations (from GenCC):
  • spondyloepiphyseal dysplasia tarda, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • spondyloepiphyseal dysplasia tarda
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant X-13712372-G-A is Benign according to our data. Variant chrX-13712372-G-A is described in ClinVar as Benign. ClinVar VariationId is 367966.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000998 (112/112224) while in subpopulation NFE AF = 0.00133 (71/53266). AF 95% confidence interval is 0.00108. There are 0 homozygotes in GnomAd4. There are 28 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 112 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001011658.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAPPC2
NM_001011658.4
MANE Select
c.*2035C>T
3_prime_UTR
Exon 6 of 6NP_001011658.1P0DI81-1
TRAPPC2
NM_001128835.3
c.*2035C>T
3_prime_UTR
Exon 6 of 6NP_001122307.2P0DI81-3
TRAPPC2
NM_014563.6
c.*2035C>T
3_prime_UTR
Exon 5 of 5NP_055378.1P0DI81-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAPPC2
ENST00000380579.6
TSL:1 MANE Select
c.*2035C>T
3_prime_UTR
Exon 6 of 6ENSP00000369953.1P0DI81-1
TRAPPC2
ENST00000683983.1
c.*2035C>T
3_prime_UTR
Exon 6 of 6ENSP00000507474.1P0DI81-3
TRAPPC2
ENST00000359680.9
TSL:1
c.*2035C>T
3_prime_UTR
Exon 5 of 5ENSP00000352708.5P0DI81-1

Frequencies

GnomAD3 genomes
AF:
0.000998
AC:
112
AN:
112170
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000947
Gnomad ASJ
AF:
0.0120
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000369
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00133
Gnomad OTH
AF:
0.00134
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.000998
AC:
112
AN:
112224
Hom.:
0
Cov.:
23
AF XY:
0.000814
AC XY:
28
AN XY:
34392
show subpopulations
African (AFR)
AF:
0.000162
AC:
5
AN:
30943
American (AMR)
AF:
0.0000946
AC:
1
AN:
10570
Ashkenazi Jewish (ASJ)
AF:
0.0120
AC:
32
AN:
2659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3587
South Asian (SAS)
AF:
0.000369
AC:
1
AN:
2707
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6071
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00133
AC:
71
AN:
53266
Other (OTH)
AF:
0.00132
AC:
2
AN:
1517
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00135
Hom.:
8
Bravo
AF:
0.000960

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Spondyloepiphyseal dysplasia tarda (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.5
DANN
Benign
0.26
PhyloP100
0.24
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41297317; hg19: chrX-13730491; API